Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Opto Circuits (India) Ltd Stock Analysis

Small Cap
Evaluated by 8389 users | BSE: 532391 | NSE: OPTOCIRCUI |
Medical Equipment/Supplies/Accessories

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Opto Circuits (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 18.24%17.94%14.21%12.47%3.48%-1.34%0.19%-20.02%0.66%1.98%-31.15%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 47260367069926314676.750.463.510562.61
Y-o-Y Gr. Rt.-27.9%11%4.4%-62.4%-44.4%-47.5%-34.3%26%65.2%-40.3%-
Adjusted EPS (Rs.) 6.559.89.6610.021.79-2.93-0.74-15.030.341.09-11.59-0.18
Y-o-Y Gr. Rt.-49.6%-1.4%3.7%-82.1%-263.7%NANANA220.6%-1163.3%-
Book Value per Share (Rs.) 35.1143.8650.0660.0161.7553.0352.2936.8239.0739.141.31.16
Adjusted Net Profit 15623823424343.3-70.9-18-3649.832.7-349-5
Net Op. Cash Flow (Rs. Cr.) 94.5118-29.5-92.9-15.755.733557.446.64221.3-
Debt to Cash Flow from Ops 2.066.13-22.29-8.75-56.0415.922.1212.4411.7812.6322.95-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Opto Circuits (India) Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -22.3%-15.6%7.5%-40.3%
Adjusted EPS -201.9%NANA-1163.3%
Book Value per Share -32.4-52.4-67.2-96.7
Share Price -33% -22.5% -31.9% -52.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 24.6424.6920.5718.22.94-5.1-1.41-33.730.982.84-57.35-14.63
Operating Profit Margin (%) 45.1840.0441.7139.4443.7336.4830.5929.7831.839.826.85-744.93
Net Profit Margin (%) 33.0139.3734.9634.7116.49-48.5-23.5-722.8315.4931.2-556.69-608.02
Debt to Equity 0.230.680.540.560.590.690.560.80.490.4512.53-
Working Capital Days 3633756099062,7744,9588,64610,2396,4713,9494,624-
Cash Conversion Cycle 2392342643601,3082,3302,2637344013-122-
Loading price chart...
Entity Percentage Holding
Promoters 18.52%
Institutions 0.98%
Non-Institutions 80.50%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Past 10 year’s financial track record indicates that that Opto Circuits (India) Ltd is a below average quality company.

Opto Circuits (India) Ltd's earnings have grown by 0%, whereas share price has declined -22.5% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Opto Circuits (India) Ltd share price has declined -33% annually (CAGR) over the past ten years.

Past 10 years financial track record analysis by Moneyworks4me indicates that Opto Circuits (India) Ltd is a below average long term investment. However, you need to ensure you buy at a right price to earn good returns.

Opto Circuits India (OCI), incorporated in the year 1992 is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries. The manufacturing is backed by a complete range of inspection and reliability testing equipments such as Bond Pull, Shear Testers, Stereo Microscopes, IR Viewers Spectrometers and

Opto Circuits India (OCI), incorporated in the year 1992 is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries. The manufacturing is backed by a complete range of inspection and reliability testing equipments such as Bond Pull, Shear Testers, Stereo Microscopes, IR Viewers Spectrometers and many more.

OCI specialize in cardiac and vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies. Its products are US FDA listed and CE marked. Some of the well-known brands marketed by the company are Criticare Systems, Mediaid, Unetixs Vascular, Eurocor and Cardiac Science.

The company has customers in USA, Europe, Middle East, Far East, South Africa etc. To service these customers it has offices through its subsidiaries in USA, Germany, Singapore and Dubai. It has subsidiaries namely Mediaid Inc (USA), Eurocor Gmbh (Germany), Criticare Systems Inc (USA), Advanced Micronic Devices (India), Devon Innovations (India), ORMED Medical Technology (India) and Altron Industries (India).

It clients includes names like Manipal Groups of hospitals, Escorts Heart Hospital, Wockhardt Heart Hospitals, Apollo Group of Hospitals, Lilavati hospital, Breach Candy Hospital are among others.

In January 2009, the company’s California-based Mediaid Inc., the subsidiary company and the international marketing arm of the company had received Brazilian FDA agency - Agencia Nacional de Vigilancia Sanitaria (ANVISA) - approval for marketing and sale of the Mediaid brand of US FDA-approved Pulse Oximetry (SPO2) products (Patient Monitors & Sensors) in the country and surrounding geographies.

During December, 2010 Opto Circuits (India) has successfully acquired 76% of outstanding common stock of Cardiac Science Corporation US. The company plans to exercise its top-up option under the terms of the merger agreement. The merger is expected to occur in the next few days. Following the merger, Cardiac Science will become a wholly-owned subsidiary of Opto Circuits (India).

Products

Health Care products- Under this segment it manufactures Pulse Oximeters, Pulse Oximeter Sensors, Fluid warmers, Digital Thermometer,Cholesterol Monitors And Stent.

Opto Electronics products- The Company manufactures Infrared Emitters, Infra Red Detectors, Photo Sensor, Detector and Emitter Assemblies.

Recognition

The company has ISO 9001-2000 and ISO 13485-2003 quality system certification.

OCI has received 2 Star Trading House Status in accordance with the provisions of Exim Policy of Federal Government of India.

Opto Circuits (India) has been featured in Forbes Asia’s 200 ‘Best Under a Billion’ List, 2011 by Forbes magazine. This is the third time the company has made it to this list, the last two times being 2008 and 2009.

Milestones

2010
- Opto Circuits acquisition of Unetixs Vascular creates strong synergies for Criticare Systems.
- Opto Circuits Successfully Completes Acquisition of Cardiac Science.
- Opto Circuits forays into manufacturing of cardiac stents - acquires Kolkata based N.S. Remedies.

2011
- Opto Circuits presents Bangalore Metro Rail Corporation Ltd. it's first public access defibrillator.
- Opto Circuits launches campaign to promote heart safe environments on World Heart Day.
- Opto Circuits ranked amongst Forbes' Asia's 200 Best Under a Billion companies for third year.

2012
- Opto Circuits launches new Powerheart G5 AED.
- Opto Circuits Supplies AEDs to 2012 UEFA European Football Championship.
- Opto Circuits launches its first Sirolimus Drug Eluting Stent."

 

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback